Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001066821 | SCV001231841 | uncertain significance | Epilepsy, familial focal, with variable foci 3 | 2020-02-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with NPRL3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with methionine at codon 25 of the NPRL3 protein (p.Arg25Met). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and methionine. |
Prevention |
RCV004547973 | SCV004796875 | uncertain significance | NPRL3-related disorder | 2024-02-16 | no assertion criteria provided | clinical testing | The NPRL3 c.74G>T variant is predicted to result in the amino acid substitution p.Arg25Met. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |